Finance

Lists
Q2 2027 earnings • released • Revenue beat +10.94%
See results
MDP:TSE
Medexus Pharmaceuticals Inc
CA$5.69
+7.16%
(+0.38) 1D
Nov 12, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDP...
Open
CA$5.49
High
CA$5.72
Low
CA$5.41
Mkt. cap
183.04M
Avg. vol.
35.27K
Volume
133.13K
P/E ratio
53.42
52-wk high
CA$5.72
52-wk low
CA$2.51
EPS
CA$0.11
Beta
1.53
Shares outstanding
31.43M
No. of employees
102
Open
CA$5.49
High
CA$5.72
Low
CA$5.41
Mkt. cap
183.04M
Avg. vol.
35.27K
Volume
133.13K
P/E ratio
53.42
52-wk high
CA$5.72
52-wk low
CA$2.51
EPS
CA$0.11
Beta
1.53
Shares outstanding
31.43M
No. of employees
102
News stories
From web sources and news partners
About Medexus Pharmaceuticals Inc
CEO-
Employees102
Founded2000
HeadquartersToronto, Ontario, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websitemedexus.com
Last report
Nov 12, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (CAD)
41.44M / 37.35M
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
24.74M
25.32M
24.65M
28.58M
Cost of goods sold
8.60M
9.39M
9.00M
10.34M
Cost of revenue
8.60M
9.39M
9.00M
10.34M
Research and development expenses
145.00K
617.00K
951.00K
728.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.92M
11.22M
10.59M
12.99M
Operating expense
14.49M
14.26M
14.00M
16.13M
Total operating expenses
23.09M
23.65M
23.00M
26.47M
Operating income
1.65M
1.68M
1.66M
2.11M
Other non operating income
-297.00K
132.00K
-1.01M
-
EBT including unusual items
-327.00K
446.00K
-3.01M
501.00K
EBT excluding unusual items
-51.00K
446.00K
-129.00K
501.00K
Income tax expense
-12.00K
366.00K
-333.00K
-43.00K
Effective tax rate
3.67%
82.06%
11.07%
-8.58%
Other operating expenses
-
-
-
-
Net income
-315.00K
80.00K
-2.68M
544.00K
Net profit margin
-1.27%
0.32%
-10.85%
1.90%
Earnings per share
-0.01
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.41M
-1.36M
-1.03M
-1.25M
Net interest expenses
-1.41M
-1.36M
-1.03M
-1.25M
Depreciation and amortization charges
72.00K
70.00K
75.00K
70.00K
EBITDA
4.08M
4.10M
3.94M
4.53M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps